Summary of presentations from the 46th annual meeting of the american society of clinical oncology (2010): Focus on developmental therapeutics related to lung cancer

Daniel Morgensztern, Nathan A. Pennell, Janakiraman Subramanian, Ramaswamy Govindan

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

A number of novel agents are currently being tested in clinical trials in patients with cancer. Results from early-phase trials, often in unselected groups of patients with a wide variety of cancer types, were reported at the 46th annual meeting of the American Society of Clinical Oncology (ASCO). We report on selected studies from the developmental therapeutics track (abstracts 2500-2613 and 3000-3108) that may be of interest to the thoracic oncology community.

Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalClinical Lung Cancer
Volume12
Issue number2
DOIs
StatePublished - Mar 2011

Keywords

  • ASCO
  • Developmental therapeutics
  • Targeted therapy

Fingerprint Dive into the research topics of 'Summary of presentations from the 46th annual meeting of the american society of clinical oncology (2010): Focus on developmental therapeutics related to lung cancer'. Together they form a unique fingerprint.

  • Cite this